EU Chemicals Strategy Advances Endocrine Society EDC Priorities

As the European Commission makes progress towards implementation of the Chemicals Strategy for Sustainability (CSS), the Endocrine Society continues to provide input to ensure that the strategy modernizes the European Union’s approach to identification and regulation of endocrine-disrupting chemicals (EDCs).

Our members are providing feedback in several different ways, including as a member of the High-Level Roundtable for the Chemicals Strategy. On November 25, the members of the Roundtable met to approve a report outlining the group’s discussions concerning enforcement and compliance of chemicals legislation.

Endocrine Society members will be vital to ongoing discussions about how best to manage human health and ecological hazards from EDCs.

The report describes the requirements of a successful enforcement and compliance structure aligned with the CSS and identifies barriers in enforcement and compliance preventing achievement of the CSS goals. We contributed to the report by offering suggestions aimed at improving the dialogue between enforcement authorities and scientists, especially in areas where new science-based legislation and regulations are forthcoming, such as for EDCs.

Meanwhile, the European Commission collected broader public input via an Open Public Consultation on the Targeted Revision of the Regulation on Classification, Labelling and Packaging of Substances and Mixtures (CLP). The CLP regulation identifies chemical hazards among different classes of substances and prescribes labeling requirements to disclose information from manufacturers to consumers about potential hazards in products.

Importantly, the Commission proposes that EDCs are considered a new hazard class that will need to be addressed in the CLP regulation. Our expert EU Task Force developed a response to the consultation focused on the need to establish clear categories for the classification of EDCs depending on the level of evidence available for each substance.

Our expert EU Task Force developed a response to the consultation focused on the need to establish clear categories for the classification of EDCs depending on the level of evidence available for each substance.

The Chemicals Strategy for Sustainability is an important component of the EU Green Deal and includes many proposed actions over the coming years to achieve a zero-pollution future. Endocrine Society members will be vital to ongoing discussions about how best to manage human health and ecological hazards from EDCs.

To become involved in the Society’s EDC advocacy, send a message to Joe Laakso, director of science policy at: [email protected]

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…